INTRODUCTION
Activation of phospholipase A2 (PLA2) with subsequent release of arachidonic acid (AA) is an important physiological and pathophysiological event. Since a serine esterase activates pancreatic phospholipase A, which is secreted as an inactive proenzyme (De Haas et al., 1968) , it has been proposed that a serine esterase may be involved in regulating the activity of intracellular PLA2. Previous reports provide support for this concept, because exposure of neutrophils and smooth-muscle cells to serine esterases may increase PLA2 activity (Kawaguchi and Yasuda, 1988; Camussi et al., 1989) . In addition, serine esterase inhibitors may prevent the increase in PLA2 activity and AA release caused in platelets by agonists such as platelet-activating factor, thrombin and the prostaglandin H2 analogue U46619 (Sugatani et al., 1987) .
Because the oxidant lipid hydroperoxide t-butyl hydroperoxide (t-Bu-OOH) increases AA release from bovine pulmonaryarterial endothelial cells by activating phospholipase A2 (Chakraborti et al., 1989) , we used this model to test the hypothesis that a membrane-associated serine esterase plays a role in the activation of PLA2. We asked the following questions: does t-Bu-OOH stimulate serine esterase activity in the endothelial-cell membrane? do changes in membrane serine esterase activity correlate with changes in PLA2 activity? do serine esterase inhibitors prevent the increase in PLA2 activity and AA release resulting from t-Bu-OOH? and does adding t-Bu-OOH or the serine esterase trypsin increase PLA2 activity in the endothelial-cell membrane fraction? Our results indicate that a and a,-proteinase inhibitor, and TAME, a synthetic substrate for serine esterase, prevent the increase in serine esterase activity, PLA2 activity and AA release caused by t-Bu-OOH. Pretreatment of the endothelial cells with the antioxidant vitamin E prevents t-Bu-OOH-induced stimulation of AA release and the cellmembrane-associated serine esterase and PLA2 activities. Adding t-Bu-OOH or the serine esterase trypsin to the endothelial-cell membrane fraction also significantly augments PLA2 activity, implying that these treatments activate latent PLA2* These results suggest that t-Bu-OOH stimulates a membrane-associated serine esterase that plays a crucial role in activating PLA2 and releasing AA.
membrane-associated serine esterase plays a crucial role in the activation of PLA2 by the oxidant t-Bu-OOH.
MATERIALS AND METHODS Materials
Dulbecco's modified Eagle's medium (DMEM) was obtained from Whittaker Bioproducts (Walkersville, MD, U.S.A.). Fetalcalf serum, L-glutamine, non-essential amino acids, gentamycin sulphate and PBS without Ca2+ and Mg2+ were purchased from GIBCO (Grand Island, NY, U.S.A.) . The trypsin used to passage the cells was obtained from GIBCO. t-Bu-OOH, di-isopropyl fluorophosphate (DFP), phenylmethanesulphonyl fluoride (PMSF), Nc-p-tosyl-L-arginine methyl ester (TAME), al-proteinase inhibitor (al-PI), elastase, fatty-acid-free BSA and unlabelled phosphatidylcholine were purchased from Sigma Chemical Co. (St. Louis, MO, U.S.A.). Type XIII trypsin (Sigma; from bovine pancreas) that had been treated with tosylphenylalanylchloromethane was used in the experiments with the endothelial-cell membrane fraction. [1-14C]AA and the phospholipid l-stearoyl-2-[1-14C]arachidonoyl-sn-glycero-3-phosphocholine were obtained from New England Nuclear (Wilmington, DE, U.S.A.) . All other chemicals were of analytical grade.
Cell culture Bovine pulmonary-arterial endothelial cells were obtained from the American Tissue Culture Collection (A.T.C.C. 209) (Rockville, MD, U.S.A.) and studied between passages 17 and 25, as Abbreviations used: t-Bu-OOH, t-butyl hydroperoxide; PLA2, phospholipase A2; AA, arachidonic acid; DFP, di-isopropyl fluorophosphate; TAME, NaWp-tosyl-L-arginine methyl ester; PMSF, phenylmethanesulphonyl fluoride; a1-PI, ac-proteinase inhibitor; DMEM, Dulbecco's modified Eagle's medium. § To whom correspondence should be addressed. 585 previously described (Chakraborti et al., 1989) . Cells were maintained in DMEM supplemented with 20 % fetal-calf serum, L-glutamine and non-essential amino acids. Cells were subcultured after treatment with 0.25 % trypsin. All experiments were performed on confluent monolayers and in serum-free DMEM supplemented with fatty-acid-free BSA (1 mg/ml).
Preparation of cell membrane fraction The endothelial-cell plasma-membrane fraction was isolated by the method of Neville (1968) with some modifications. Briefly, the endothelial cells grown in T-1 50 flasks were washed twice with ice-cold PBS. The cells were then scraped from the flasks and suspended in ice-cold homogenizing medium containing 0.25 M sucrose and 5 mM Tris/HCl buffer (pH 7.4) and homogenized by using a Dounce homogenizer with a tight-fitting pestle. The homogenate was then strained through cheesecloth and successively centrifuged at 13 000 g for 30 min and at 80000 g for 1 h at 4 'C. The 80000 g pellet was suspended in 2.5 ml of 10% (w/v) sucrose containing 10 mM Tris/HCl (pH 7.4) and was layered on a discontinuous gradient consisting of 40 % (w/v) and 20 % (w/v) sucrose both containing 10 mM Tris/HCl (pH 7.4). The gradient was centrifuged at 100000 g for 2 h at 4 'C in a Spinco LSW 27 rotor (Beckman). The fraction collected at the 20 %/40% -sucrose interface was diluted with 10 mM Tris/HCl (pH 7.4) and was used as the cell-membrane fraction. Protein concentrations were assayed as described by Lowry et al. (1951) .
Assay of 5'-nucleotidase and acid phosphatase activities In the membrane fraction Release of Pi from 5'-AMP, an index of 5'-nucleotidase activity, was measured by the method of Chen et al. (1956) . Acid phosphatase activity was determined at pH 5.5 with p-nitrophenyl phosphate as the substrate (Fleischer and Packer, 1974 ).
Measurement of [14C]AA release
Cells grown on 6-well plates were washed twice with PBS and incubated for 20 h with [14C]AA (2,Ci/well). After incubation, the supernatant was removed and the cells were washed twice with PBS. To measure t-Bu-OOH-mediated AA release, cells were exposed for 15 min to 300 ,uM t-Bu-OOH in serum-free DMEM supplemented with 1 mg/ml fatty-acid-free BSA.
[14C]AA release was determined as previously described (Chakraborti et al., 1989) .
Assay of PLA2 activity in vitro
Endothelial monolayers were washed twice with PBS (pH 7.2). The cells were then removed in PBS with a rubber policeman and the cell membrane fraction was isolated as described above. A 20 1ed portion of the membrane preparation (2-3 mg of protein) was added to 30 ,ul of the reaction mixture which contained (final concns.): Tris buffer (100 ,uM), NaCl (100 mM), deoxycholate (1 mM), and the phospholipid L-3-phosphatidylcholine, i.e. I-stearoyl-2-[-1_4C]arachidonoyl-sn-glycero-3-phosphocholine (10 ,uM). PLA2 activity was assayed at pH 9.0, which is the optimal pH when phosphatidylcholine is used as the substrate (Clark et al., 1986 ).
The phospholipid l-stearoyl-2-[l-'4C]arachidonoyl-sn-glycero-3-phosphocholine was evaporated under N2, resuspended in deoxycholate (5 mM), sonicated in a water-bath sonicator, and added to the assay mixture in a volume of 10 4u1. The reaction mixture was allowed to incubate for 1 h at 37°C, and then the reaction was stopped by addition of 50,1 of chloroform/ methanol (2: 1, v/v), followed by addition of 50 1ul of chloroform and 50 1ld of 4 M KCI. This mixture was centrifuged at 12000 g in a microfuge to separate the organic and aqueous phases. The organic phase was removed, applied to a silica-gel t.l.c. plate (Analtech, Newark, DE, U.S.A.), and chromatographed in chloroform/methanol/acetic acid/water (25:15:4:2, by vol.) to separate the phosphatidylcholine from the major product produced by phospholipase A2 activity, i.e. lysophospholipid. Authentic standards were chromatographed with the lipid extract to locate the compounds of interest, and these components were scraped from the plate and counted by liquid-scintillation spectroscopy. PLA2 activity was quantified as the release of the free fatty acid from phosphatidylcholine. Unlabelled phosphatidylcholine was added to the labelled phosphatidylcholine to give a specific radioactivity of 510 mCi/mmol (Clark et al., 1986 ).
Effect of serine esterase Inhibitors and vitamin E
To determine the effect of the serine esterase inhibitors on basal and t-Bu-OOH-stimulated AA release and PLA2 activity, cells were pretreated with PMSF (1 mM), DFP (1 mM) and al-PI
(1 mg/ml) for 20 min before adding t-Bu-OOH. To investigate the effect of vitamin E pretreatment, the endothelial cells were pretreated with vitamin E (1 mM) for 20 min before adding t-Bu-OOH (300 #M).
Effect of trypsin and t-Bu-OOH on PLA2 activity in the endothellalcell membrane fraction Bovine pulmonary-arterial endothelial cells grown in T-1 50 flasks were washed twice with PBS (pH 7.2). The cells were then removed with a rubber policeman, and the cell membrane fraction was isolated by the procedure described above. The membrane fraction was then treated with trypsin (1 4ug/ml) for 15 min at 37°C, and PLA2 activity was measured as described above. To determine whether serine esterase inhibitors would block the increase in PLA2 activity caused by trypsin, the endothelial-cell membrane fraction was pretreated for 20 min with PMSF (1 mM), DFP (1 mM) and al-PI (1 mg/ml) before adding trypsin.
To test whether or not t-Bu-OOH augments PLA2 activity, the cell membrane fraction was treated with t-Bu-OOH (300 ,uM) alone or combined with trypsin (1 ,tg/ml).
Determination ofi esterase activity endothelial-call membrane-associated serine Serine esterase activity was assessed by determining the hydrolysis of the synthetic substrate TAME, by the method of Hummel (1959) . Briefly, 300 Iul of the substrate (37.9 mg/10 ml of water) was added to 2.4 ml of 0.05 M Tris buffer containing 10 mM CaCl2 (pH 8.5). The reaction was initiated by adding 50 ,tg of the endothelial-cell membrane fraction, giving a final reaction volume of 3 ml. Hydrolysis was measured as an increase in A247. A blank without enzyme activity was included to monitor for spontaneous hydrolysis of the substrate. To determine the effect of t-Bu-OOH on serine esterase activity, the endothelial cells were exposed to t-Bu-OOH (300 ,uM) for 15 min. The membrane fraction was isolated and serine esterase activity was determined as described above. To determine the effect of the serine esterase inhibitors PMSF (1 mM), DFP (1 mM) and al-PI (1 mg/ml) on the increase in serine esterase activity caused by t-Bu-OOH, cells were pretreated with the above inhibitors for 20 min before addition of t-Bu-OOH.
Comparison of the endothelial-cell membrane-associated serine esterase with elastase and cathepsin G Azocasein degradation Cleavage of azocasein was determined by the method of Starkey and Barrett (1976) . Portions (50 jig) of elastase, cathepsin G or endothelial-cell membrane were added to 0.5 ml of an azocasein solution (6 % in 0.1 M Tris, pH 7.0), and the final volume was adjusted to 1.0 ml by addition of 0.1 M Tris. This reaction mixture was incubated at 37°C for 90 min, precipitated with 3 ml ofcold 5 % trichloroacetic acid, and then centrifuged at 200 g for 10 min. The supernatant was removed and the A410 was measured.
Haemoglobin degradation Haemoglobin degradation was determined by a modification of the method originally described by Anson (1940) . Portions (50 jtg) of elastase, cathepsin G or the endothelial-cell membrane were incubated with 1 % non-denatured haemoglobin in 0.01 M PBS (pH 7.2) at 37°C for 20 h. The suspension was then precipitated with 5 % trichloroacetic acid and pelleted by centrifugation at 10000 g for 10 min. The A280 of the supernatant was measured.
Cleavage of synthetic peptides Synthetic chromogenic peptide substrates were used to characterize the endothelial-cell membrane-associated serine esterase. We used Suc-Ala3-pNA and Suc-Ala2-Val-pNA as substrates for elastase and Suc-Ala2-Pro-Phe-pNA as a substrate for chymotrypsin-like enzymes (Suc, succinyl; pNA, p-nitroanilide). To assess the activity of the serine esterases for these substrates, we used with some modifications the method described by Barrett (1981) . Briefly, 50,u1 of the substrate (1 ,ug/ml of dimethyl sulphoxide) was added to 0.1 M Tris/HCl buffer (pH 7.0). The reaction was initiated by adding 50 ,ug of elastase, cathepsin G or the endothelial-cell membrane fraction. The final reaction volume was adjusted to 3 ml. Cleavage was measured by the increase in A410.
Statistical analysis
Data were analysed by unpaired t test, repeated-measures analysis of variance, and the Duncan multiple-range test for group comparisons (Snedecor and Cochran, 1980) . Statistical significance was assumed when P < 0.05.
RESULTS
In bovine pulmonary-arterial endothelial cells, the oxidant lipid hydroperoxide t-Bu-OOH increases the activity of a membraneassociated serine esterase, the activity of PLA2, and the release of [14C]AA (Table 1) . Pretreatment of the endothelial cells with PMSF, DFP and a,-PI decreases serine esterase activity, PLA2 activity and AA release under basal conditions (Table 1) . These inhibitors also prevent the increase in serine esterase activity, PLA2 activity and AA release caused by t-Bu-OOH (Table 1) . Changes in the activity of the membrane-bound serine esterase correlate directly with changes in the activity of membrane PLA2 (Figure 1) . Pretreatment of the cells with vitamin E also prevents the t-Bu-OOH-induced increase in serine esterase activity, PLA2 activity and AA release (Table 1) .
We characterized the membrane fraction by measuring at different steps in the preparation process the activity of acid phosphatase, a lysosomal enzyme, and the activity of 5'-nucleotidase activity, an endothelial plasma-membrane marker (Ketis et al., 1986) (Table 2) . Compared with the crude membrane pellet, the membrane fraction has a 16-fold decrease in specific activity of acid phosphatase and a 12-fold increase in specific activity of the plasma-membrane marker 5'-nucleotidase.
The endothelial-cell membrane-associated serine esterase appears distinct from elastase, cathepsin G or chymotrypsin. For Table 3 Characteristics of bovine pulmonary-arterial endothellal cell membrane-associated serine esterase compared with elastase and cathepsin G
The activity of each serine esterase is expressed compared with the activity of the enzyme that is most reactive with each substrate. The activity of the most reactive enzyme was defined as 100%. Values shown are percentage activities (means+ S.E.M.; n = 4). example, it differs from elastase and cathepsin G in its inability to degrade azocasein and haemoglobin (Table 3 ). In addition, this serine esterase does not cleave synthetic substrates for elastase, such as Suc-Ala3-pNA and Suc-Ala2-Val-pNA, or a substrate for chymotrypsin-like enzymes, Suc-Ala2-Pro-Phe-pNA (Table 3 ). In contrast, TAME is a synthetic substrate for the endothelial-cell membrane-associated serine esterase, but not for elastase or cathepsin G (Table 3) .
Endothelial
To test further the hypothesis that a serine esterase can activate intracellular PLA2, we treated the endothelial-cell membrane fraction with trypsin. Trypsin markedly stimulates membrane-associated PLA2 activity, and serine proteinase inhibitors prevent the increase in PLA2 activity caused by trypsin (Table 4 ). The oxidant t-Bu-OOH also strikingly increases PLA2 activity in the endothelial-cell membrane fraction (Table 4) . Combined treatment of the endothelial-cell membrane fraction with t-Bu-OOH and trypsin further augments PLA2 activity compared with the effect of trypsin or t-Bu-OOH alone (Table 4) .
DISCUSSION
Given the potency of the metabolic products of AA, the activity of intracellular PLA2 must be tightly regulated. The biochemical mechanisms involved in the regulation of intracellular PLA2, however, are poorly understood. Since pancreatic phospholipase A is secreted in an inactive form, which is then activated by serine esterases, it has been suggested that serine esterases may also play a role in regulating intracellular PLA2 activity. Previous studies have found, for example, that exogenous serine esterases may stimulate AA release from smooth-muscle cells and neutrophils by increasing PLA2 activity (Camussi et al., 1989; Kawaguchi and Yasuda, 1988) . In addition, serine esterase inhibitors appear to prevent the increase in PLA2 activity caused by platelet-activating factor or tumour necrosis factor (Camussi et al., 1989; Sugatani et al., 1987) . These previous reports provide indirect evidence that a serine esterase may participate in activating PLA2. To test further the hypothesis that a membraneassociated serine esterase plays an important role in regulating intracellular PLA2, we used the oxidant lipid t-Bu-OOH, which we have previously shown stimulates AA release in bovine pulmonary-arterial endothelial cells by increasing PLA2 (Chakraborti et al., 1989) .
Several lines of evidence indicate that a serine esterase plays an important role in the increased AA release and PLA2 activity caused by the oxidant t-Bu-OOH. First, we have previously shown that bovine pulmonary-artery endothelial cells contain a membrane-associated serine esterase (Chakraborti and Michael, 1991) . The endothelial-cell membrane-associated serine esterase has an Mr of 29 000, which is similar to that of other members of the serine esterase family (Chakraborti and Michael, 1991) . The identity of this serine esterase is unknown, but it has characteristics that distinguish it from elastase and cathepsin G (Table  3) . Secondly, t-Bu-OOH not only augments PLA2 activity and AA release, but also increases the activity of a membraneassociated serine esterase (Table 1) . t-Bu-OOH appears to produce these effects via an oxidant species, because pretreatment of the cells with vitamin E prevents the increase in serine esterase activity, PLA2 activity and AA release (Table 1) . Thirdly, changes in the activity of the membrane-associated serine esterase correlate directly with changes in the activity of membrane PLA2 (Figure 1) . Fourthly, serine esterase inhibitors decrease basal serine esterase activity, PLA2 activity and AA release (Table 1) . Fifthly, these inhibitors also prevent the t-Bu-OOH-mediated increase in serine esterase activity, PLA2 activity and AA release. Sixthly, adding trypsin to an endothelial-cell membrane fraction markedly increases PLA2 activity, indicating that a serine esterase can activate latent PLA2 activity in endothelial cells (Table 4) . Seventhly, t-Bu-OOH also increases PLA2 activity in an endothelial-cell membrane fraction, implying that this oxidant also converts inactive PLA2 into an active form (Table 4) .
In summary, our results indicate that a membrane-associated serine esterase appears to play an important role in regulating PLA2 and that one mechanism for the increase in PLA2 activity caused by the oxidant t-Bu-OOH is probably an increase in the activity of this serine esterase. The identity of this serine esterase is currently under investigation. How the oxidant t-Bu-OOH increases the activity of the serine esterase, or how the serine esterase contributes to the activation of PLA2, is currently unknown. Conceivably, the serine esterase may regulate PLA2 activity directly or via an effect on other regulators of PLA2, such as intracellular Ca2+, protein kinase C, PLA2-activating protein (Clark et al., 1987 (Clark et al., , 1988 , or lipocortin. 
